Navigation Links
Neurocrine Biosciences Reports Third Quarter 2012 Results
Date:10/31/2012

SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter and nine months ended September 30, 2012. For the third quarter of 2012, the Company reported a net loss of $3.1 million, or $0.05 loss per share, compared to net income of $31.4 million, or income of $0.56 per fully diluted share outstanding, for the same period in 2011. For the nine months ended September 30, 2012, the Company reported a net loss of $4.5 million, or $0.07 loss per share, compared to net income of $36.2 million, or income of $0.64 per fully diluted share outstanding, for the first nine months of last year. During the third quarter of 2011, the Company recognized $30.0 million in milestone revenue under its collaboration agreement with Abbott.

The Company's balance sheet at September 30, 2012 reflected cash, cash equivalents, investments and receivables under collaboration agreements of $185.5 million. 

"Neurocrine continued to advance its development pipeline with our VMAT2 inhibitor entering Phase IIb clinical trials this past quarter," said Christopher O'Brien, Chief Medical Officer of Neurocrine Biosciences. "The KINECT study, along with the pending second Phase IIb study of NBI-98854 in tardive dyskinesia patients as well as information from the elagolix program will provide significant data flow over the coming quarters."

"Significant progress has also been made with elagolix," said Kevin Gorman, Chief Executive Officer of Neurocrine Biosciences. "The Phase III study for elagolix in endometriosis is enrolling as planned, and the Phase II clinical trial in uterine fibroids is anticipated to complete in the first half of next year."

Revenues for the third quarter of 2012 were $9.4 million, compared to $41.6 million for the same period in 2011. Revenues for the nine months ended September 30,
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
2. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
3. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
4. Neurocrine Biosciences Reports Second Quarter 2012 Results
5. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
6. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
7. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
9. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
10. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
11. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... SHENZHEN, China , July 22, 2014 /PRNewswire/ ... a subsidiary of BGI, the world,s largest genomics ... new human whole exome sequencing service based on ... includes in-depth bioinformatics analysis and SNP validation, and ... 2014. Complete Genomics, highly regarded ...
(Date:7/22/2014)... PORTLAND, Ore. , July 22, 2014 /PRNewswire/ ... "Semler"), an emerging medical risk assessment company that ... monitoring patients and evaluating chronic diseases, today announced ... results before the open of U.S. financial markets ... of Semler will host a conference call at 11 ...
(Date:7/22/2014)... 22, 2014  United Therapeutics Corporation (NASDAQ: ... release its second quarter 2014 financial results before ... United Therapeutics will host a half-hour teleconference ... Eastern Time.  The teleconference is accessible by dialing ... of the teleconference will be available for one ...
(Date:7/22/2014)... Lawrence, KS (PRWEB) July 22, 2014 ... as attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication ... trial and error. Analyzing brain patterns by using electroencephalography ... best result and thus lower the risk of adverse ... Electroencephalography Phenotypes and Biomarkers” in the current issue ...
Breaking Biology Technology:BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3
... SAN FRANCISCO, May 10, 2011 Date: ... ranking the 500 fastest growing technology, media, telecommunications, life sciences, and ... of the Technology Fast 500™. What:   Nominations ... revenue growth over fiscal years 2006 to 2010.  To be eligible ...
... DATATRAK International, Inc. (OTCQX: DATA), a technology and ... clinical trials industry, today announces the expansion of its ... Community College (DTCC) to license its DATATRAK eClinical® software ... software in its Clinical Trials Research program and courses. ...
... COLLEGE PARK, Md., May 9, 2011 The Maryland ... the 2011 University of Maryland $75K Business Plan Competition ... Winning student and faculty teams were selected from 71 initial ... 6 to teams of expert judges as well as a ...
Cached Biology Technology:Deloitte Seeks Nominations for 2011 Technology Fast 500™ Ranking 2DATATRAK Academy Expands to Include Durham Technical Community College 2DATATRAK Academy Expands to Include Durham Technical Community College 3Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition 2Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition 3Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition 4Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition 5
(Date:7/22/2014)... and engineering professor with an expertise in big data ... grant worth more than $600,000 to develop an interactive ... Huang, an associate professor, will lead the project with ... Science and Engineering department. Scientists are compiling and studying ... of genes involved in fruit fly development are commonly ...
(Date:7/22/2014)... the Monell Center reveals that simply believing that an ... asthmatics for at least 24 hours following exposure. The ... health-related outcomes. , "Asthmatics often are anxious about scents ... harmful, our bodies react as if that odor is ... a Monell physiologist. "Both patients and care providers need ...
(Date:7/22/2014)... not be good for the average steak, but it ... prepare to survive Alaska,s winter cold. , "Alaska wood ... a steak does in your freezer and the frog ... shape than the steak," said Don Larson, University of ... recent paper demonstrating that freeze tolerance in Alaska wood ...
Breaking Biology News(10 mins):UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2In asthma, it's not just what you smell, but what you think you smell 2In asthma, it's not just what you smell, but what you think you smell 3Alaska frogs reach record lows in extreme temperature survival 2Alaska frogs reach record lows in extreme temperature survival 3
... sees the use of terahertz rays as a critical ... terrorist activities. Federici and his research team recently ... in their laboratory that uses a terahertz imaging system. ... to scan airport passengers quickly and efficiently. "Video-Rate terahertz ...
... United States and Europe has identified more than a dozen ... common forms of kidney disease. The team, known as the ... than 65,000 individuals of European descent. Common variations in several ... poor kidney function or chronic kidney disease than in those ...
... than one third of Americans are considered obese and approximately ... (BMI) greater than 40. The April issue of the ... ever-increasing use of bariatric surgery to control the excess morbidity ... that registered dietitians play in the management of patients who ...
Cached Biology News:NJIT physicist sees terahertz imaging as ultimate defense against terrorism 2NJIT physicist sees terahertz imaging as ultimate defense against terrorism 3International research team discovers novel genes influencing kidney disease risk 2Registered dietitians play essential role in management of gastric bypass patients 2Registered dietitians play essential role in management of gastric bypass patients 3
... to ARG. Vasopressin The antibody ... Cells are found in the paraventricular ... found throughout the hypothalmus in rat ... Immunogen: Arginine ...
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
Sheep polyclonal to Malate Dehydrogenase ( Abpromise for all tested applications). Antigen: Full length protein - Pig heart malate dehydrogenase. Entrez Gene ID: 4190 Swiss Protein ID: P...
Biology Products: